Detalles de la búsqueda
1.
Long-term follow-up of a prospective phase 2 clinical trial of extended treatment with rituximab in patients with B cell post-transplant lymphoproliferative disease and validation in real world patients.
Ann Hematol
; 100(4): 1023-1029, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32367180
2.
High clinical and molecular response rates with fludarabine, cyclophosphamide and mitoxantrone in previously untreated patients with advanced stage follicular lymphoma.
Haematologica
; 93(2): 207-14, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18223288
3.
Prospective phase II trial of extended treatment with rituximab in patients with B-cell post-transplant lymphoproliferative disease.
Haematologica
; 92(11): 1489-94, 2007 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18024397
4.
Isoform-selective phosphoinositide 3-kinase inhibitors induce apoptosis in chronic lymphocytic leukaemia cells.
Br J Haematol
; 150(1): 108-11, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20230409
5.
Type 2 diabetes mellitus, its treatment and risk for lymphoma.
Eur J Cancer
; 41(12): 1782-7, 2005 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16039111
6.
Family clustering of blood cancers as a risk factor for lymphoid neoplasms.
Haematologica
; 90(3): 416-8, 2005 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-15749682
7.
High dose chemotherapy and autologous stem cell transplantation in patients with peripheral T-cell lymphoma not achieving complete response after induction chemotherapy. The GEL-TAMO experience.
Haematologica
; 88(12): 1372-7, 2003 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-14687990
8.
Refractory cold agglutinin-immunohaemolytic anaemia associated to marginal zone lymphoma responding to rituximab.
Hematol J
; 4(6): 450-1, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-14671620
9.
Cost-effectiveness of primary antifungal prophylaxis with posaconazole versus itraconazole in allogeneic hematopoietic stem cell transplantation.
J Med Econ
; 16(6): 736-43, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23541251
10.
Relationship between deoxycytidine kinase (DCK) genotypic variants and fludarabine toxicity in patients with follicular lymphoma.
Leuk Res
; 35(4): 431-7, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21030078
11.
Prospective study of clinical and biological prognostic factors at diagnosis in patients with early stage B-cell chronic lymphocytic leukemia.
Leuk Lymphoma
; 52(3): 429-35, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21323523
12.
Analysis of apoptosis regulatory genes altered by histone deacetylase inhibitors in chronic lymphocytic leukemia cells.
Epigenetics
; 6(10): 1228-35, 2011 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21931276
13.
Frontline treatment of follicular lymphoma with fludarabine, cyclophosphamide, and rituximab followed by rituximab maintenance: toxicities overcome its high antilymphoma effect. Results from a Spanish Cooperative Trial (LNHF-03).
Leuk Lymphoma
; 52(3): 409-16, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21275633
14.
MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells.
Blood
; 107(10): 4109-14, 2006 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16439685
15.
Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma.
Blood
; 108(2): 662-8, 2006 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16551964
Resultados
1 -
15
de 15
1
Próxima >
>>